The Alpha IMS piece will benefit blind patients who lost their eyesight due to conditions such as retinitis pigmentosa. These patients still have their vision neurons in place, enabling the advanced tech tool to process light once implanted into the brain.
The Alpha IMS is different from its predecessors in that it does not use a camera to interpret signals. Instead, it is composed of a 15000 electrode grid. The grid sits beneath the retina, enabling patients to interpret their exterior environments via the eye's neurons. Clinical testing has revealed its efficacy, especially as it comes equipped with a dial along one's ear that allows for the personal adjustment of brightness and a pocket-based battery.
Sight-enabling Implants
The Alpha IMS Device Enables Blind Patients to See Once More
Trend Themes
1. Sight-enabling Implants - Implants that enable blind patients to see once more via the use of a 15000 electrode grid placed beneath the retina in the brain.
2. Retinitis Pigmentosa - A degenerative eye disease that causes blindness and creates a market for sight-enabling implants such as the Alpha IMS.
3. Neural Implants - The use of implantable technology to restore lost functions such as vision and hearing.
Industry Implications
1. Healthcare - The healthcare industry can benefit greatly from neural implants and other implantable technologies.
2. Medical Technology - The medical technology industry has vast potential to create innovative implantable devices for various medical needs.
3. Biotechnology - The biotechnology industry can leverage implantable technology to create innovative solutions for unmet medical needs.